Where to buy NAD+.

NAD+ is the most-confused molecule in the longevity research catalog. It’s sold under three names (NAD+, NMN, NR), at three price points, with three completely different evidence bases. Where to buy NAD+ for research in 2026 requires resolving one question first: is the target molecule the cofactor itself, or a precursor (NMN or NR)? This guide covers the IV clinic markup, the oral precursor data, and the mass-spec check that confirms which molecule actually shipped.

Three sourcing channels, and what each one offers

NAD+ has more channels than most peptides because it’s a small molecule, not a drug. Three options for actually getting it:

• IV NAD+ at a clinic: $500–$1,500 per session. Doctor on staff. 2–4 hour slow drip. The clinic uses a compounding pharmacy for material. No FDA approval for the marketed indications. Flush reactions (chest tightness, facial flushing, anxiety) are routine.
• Oral NMN or NR supplements: $60–$80 per month. No prescription. The molecule with most of the human RCT data. FDA rejected NMN as a dietary supplement in 2022, but enforcement has been patchy.
• Research-supply NAD+: $75–$300 per vial. Lyophilized powder under Research Use Only labeling. No prescription.

Identity and mechanism of NAD+

NAD+ is a cellular cofactor essential for metabolism. It carries electrons in cellular respiration. It feeds sirtuin enzymes (SIRT1 through SIRT7) and PARP enzymes (the ones that repair DNA). It also gets degraded by CD38, which rises with age (Covarrubias et al., 2021).

Here’s the wrinkle. NAD+ levels drop with age, which has fueled massive interest in “NAD+ boosting.” But the published human RCT evidence isn’t on direct NAD+. It’s on the oral precursors (NMN and NR).

The 2023 GeroScience dose-response trial randomized 80 middle-aged adults to placebo, 300, 600, or 900 mg NMN for 60 days. Blood NAD+ rose significantly in all NMN groups (Yi et al., 2023). That’s the molecule with the trial data. Not the IV NAD+ marketed by clinics.

The four checks that matter for NAD+

The standard eight vendor criteria apply. Four are sharper here.

1. NAD+ vs NMN vs NR: molecular identity verification

This is the single most important step. The three molecules are not interchangeable:

• NAD+: MW 663.43, CAS 53-84-9. The cofactor itself.
• NMN (nicotinamide mononucleotide): MW 334.22, CAS 1094-61-7. The direct precursor. Most of the human trial data lives here.
• NR (nicotinamide riboside): MW 255.23, CAS 1341-23-7. Sold as NIAGEN by ChromaDex. Multiple human trials.

Vendors sometimes brand NMN or NR products as “NAD+ supplement” in the marketing copy while the ingredient line says NMN. Mass-spec catches it: NAD+ at [M+H]⁺ 664.4, NMN at 335.2, NR at 256.2. Hundreds of daltons apart. The test is unambiguous.

2. Form: lyophilized, light-protected, frozen

NAD+ is unstable in solution. The chemical bonds hydrolyze. Light degrades it. Oxygen oxidizes it. The stable shipping form is lyophilized powder, light-protected, kept at −20°C.

Pre-reconstituted NAD+ at room temperature ships with an unknown concentration at point of use. Nasal sprays and sublingual lozenges add a worse problem: NAD+ is a big polar molecule, and neither route has been validated in any published study.

3. Purity threshold: ≥99% HPLC, not ≥98%

Cofactor-grade standards are tighter than peptide standards. Where ≥98% is the peptide benchmark, ≥99% HPLC is the cofactor benchmark. Below 95%, the sample likely contains degradation byproducts (nicotinamide, ADP-ribose, ADP) that will confound experiments.

4. The IV-clinic markup, decoded

Research-grade NAD+ runs $75–$150 per 500 mg vial. The $1,000 IV-clinic price is real, but the material cost is a small slice: a 1,000 mg IV dose uses roughly $150 of NAD+. The rest is IV equipment, nursing labor, the 2–4 hour slow drip needed to avoid flush reactions, and clinic overhead. See NAD+ IV vs oral precursors for the full math.

NAD+

Cofactor MW 663.43 Lyophilized

The dinucleotide cofactor itself — not the cheaper NMN or NR precursor that vendors sometimes label as “NAD.” The same reference compound discussed across the 2021 Nature Reviews Mol Cell Biol NAD+ metabolism overview and the oral-precursor RCT literature anchoring our IV-vs-oral analysis. CAS 53-84-9, mass-spec confirmed at [M+H]⁺ 664.4, ≥99% HPLC purity, ISO 17025 third-party CoA on every lot.

View NAD+

2026 pricing benchmarks

NAD+ pricing varies more than peptide pricing because of the cofactor-vs-research-grade split. The 2026 retail map:

• 100 mg vial: $40–$80 ($0.40–$0.80/mg).
• 500 mg vial: $75–$150 ($0.15–$0.30/mg). Most common size. Best per-mg value for lab use.
• 1 g vial: $140–$280 ($0.14–$0.28/mg). Common for IV-clinic procurement.
• IV NAD+ clinic session: $500–$1,500 per 500–1,000 mg infusion. About $150 of material; the rest is clinic markup.

Below $30 per 500 mg vial, the pricing likely reflects partial degradation, underdosing, or rebranded NMN at NAD+ pricing. Above $0.40 per mg, the premium typically represents retail markup rather than synthesis cost.

The legal picture

NAD+ regulatory status splits three ways:

• Research-use NAD+: Legal under 21 CFR § 809.10(b)(9) Research Use Only labeling. Not for human use.
• Oral NAD+ supplements: Not FDA-approved. Oral NAD+ also has poor bioavailability. The 2022 FDA rejection of NMN as a dietary supplement (on grounds it was being studied as a drug) was the more important decision in this lane.
• IV NAD+ at clinics: Sold via compounding pharmacies with no FDA approval for any specific indication. Operates under a different regulatory framework from research-compound sales.

WADA has not explicitly listed NAD+ or its precursors as of 2026.

Red flags specific to NAD+

• Vial labeled “NAD” without specifying NAD+, NMN, or NR. Three molecules. Hundreds of daltons apart. An order of magnitude apart in price.
• Nasal sprays or sublingual lozenges with stability claims. Neither route has been validated for NAD+ in any published controlled study.
• Pre-reconstituted solution at room temperature. NAD+ is unstable in solution; actual concentration at point of use is unknown without re-testing.
• Purity below ≥99% HPLC. Below 95%, the sample is likely to contain degradation byproducts.
• Pricing below $30 per 500 mg vial. Usually means degradation, underdosing, or rebranded NMN.
• Mass-spec not matching 664.4 [M+H]⁺. 335.2 means it’s NMN. 256.2 means it’s NR. No mass-spec at all means unverified identity.
• Clinical claims on the product page. “Treats addiction.” “Reverses aging.” That’s FDA jurisdiction.

NAD+

500 mg ≥99% pure Powder

500 mg of cofactor-grade NAD+ at ≥99% HPLC purity — the same molecule discussed across our IV vs oral precursors cost-effectiveness analysis. Lyophilized pale-yellow powder, CAS 53-84-9, mass-spec confirmed at [M+H]⁺ 664.4. COA with HPLC trace and mass-spec ships with every order.

Learn more

Frequently asked questions

Is NAD+ legal to buy?

Yes, as a research reference compound. NAD+ is a natural coenzyme present in every living cell. It’s not a controlled substance. The regulatory complications sit elsewhere: oral NAD+ isn’t FDA-approved as a supplement, IV NAD+ ships through compounding pharmacies without FDA approval for marketed indications, and the FDA rejected NMN as a dietary-supplement ingredient in 2022.

How much should NAD+ cost?

$75–$150 per 500 mg vial at the cofactor-grade end. $80–$300 across the broader market. IV clinics bill $500–$1,500 per session, but the material cost is about $150. Below $30 per 500 mg vial means partial degradation, underdosing, or rebranded NMN.

NAD+ vs NMN vs NR, which is best?

Three different molecules. NAD+ is the cofactor itself. NMN is the direct precursor. NR converts to NMN first. The published human-trial evidence sits with oral NMN and NR, not direct oral NAD+ (which has poor bioavailability). Research designed to align with the published precursor literature typically uses the NMN or NR form rather than NAD+ directly.

Why is IV NAD+ so expensive?

Material cost is about $150 per 1,000 mg dose. The rest of the $500–$1,500 session price is IV equipment, nursing labor, the 2–4 hour slow drip required to prevent flush reactions, and clinic markup. Whether IV beats oral NMN at a fraction of the cost is contested. See IV vs oral analysis.

Can I buy NAD+ without a prescription?

Yes, for research-grade powder under Research Use Only labeling. Clinical IV NAD+ at a clinic requires physician oversight and a compounding pharmacy. Two completely separate markets.

What should an NAD+ Certificate of Analysis show?

HPLC purity ≥99% with chromatogram. Mass-spec at [M+H]⁺ 664.4. CAS 53-84-9 on the identity line. Karl Fischer water content. Residual solvents per ICH Q3C (a pharmaceutical industry standard). Bacterial endotoxin testing if parenteral research is intended. An ISO 17025-accredited lab on the report. A CoA that doesn’t separately confirm NAD+ (rather than NMN or NR) is a critical gap.